Adjunctive ultrasonography for breast cancer screening

Affiliations

¹ Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.
² Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK. Electronic address: compare-team@ebmdatalab.net.

Comment

Aaron Dale et al. Lancet. 2016.

. 2016 Jun 11;387(10036):2379-80.

doi: 10.1016/S0140-6736(16)30735-8.

¹ Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.
² Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK. Electronic address: compare-team@ebmdatalab.net.

No abstract available

Comment in

Adjunctive ultrasonography for breast cancer screening - Authors' reply.
Ohuchi N, Suzuki A, Yamamoto S, Kuriyama S, Ishida T. Ohuchi N, et al. Lancet. 2016 Jun 11;387(10036):2381-2. doi: 10.1016/S0140-6736(16)30670-5. Lancet. 2016. PMID: 27312308 No abstract available.

Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial.
Ohuchi N, Suzuki A, Sobue T, Kawai M, Yamamoto S, Zheng YF, Shiono YN, Saito H, Kuriyama S, Tohno E, Endo T, Fukao A, Tsuji I, Yamaguchi T, Ohashi Y, Fukuda M, Ishida T; J-START investigator groups. Ohuchi N, et al. Lancet. 2016 Jan 23;387(10016):341-348. doi: 10.1016/S0140-6736(15)00774-6. Epub 2015 Nov 5. Lancet. 2016. PMID: 26547101 Clinical Trial.